{"id":"7vpnc","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, swelling, or bruising at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"7vPnC is a conjugate vaccine that combines the meningococcal serogroup B and Y capsular polysaccharides with a diphtheria toxoid carrier protein. This conjugation enhances the immune response and provides protection against meningococcal disease caused by these serogroups.","oneSentence":"7vPnC is a vaccine that protects against meningococcal disease caused by serogroups B and Y.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:43:54.152Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of meningococcal disease caused by serogroups B and Y in individuals 10 through 25 years of age"}]},"trialDetails":[{"nctId":"NCT00688870","phase":"PHASE3","title":"Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2008-06-05","conditions":"Vaccines, Pneumococcal Conjugate Vaccine","enrollment":168},{"nctId":"NCT01200368","phase":"PHASE3","title":"Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-09-24","conditions":"Healthy Subjects","enrollment":551},{"nctId":"NCT01521897","phase":"","title":"Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-09","conditions":"Pneumococcal Vaccine, Streptococcus Pneumoniae","enrollment":1143},{"nctId":"NCT01692886","phase":"PHASE3","title":"A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-08","conditions":"Pneumococcal Infection","enrollment":1674},{"nctId":"NCT00508742","phase":"PHASE3","title":"Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-12","conditions":"Pneumococcal Infections","enrollment":1866},{"nctId":"NCT01250756","phase":"PHASE4","title":"A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-11","conditions":"Healthy Subjects","enrollment":321},{"nctId":"NCT00366899","phase":"PHASE3","title":"Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-10","conditions":"Vaccines, Pneumococcal","enrollment":605},{"nctId":"NCT00373958","phase":"PHASE3","title":"Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-09","conditions":"Vaccines, Pneumococcal","enrollment":666},{"nctId":"NCT00384059","phase":"PHASE3","title":"Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-10","conditions":"Vaccines, Pneumococcal","enrollment":286},{"nctId":"NCT00444457","phase":"PHASE3","title":"Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2007-05","conditions":"Vaccines, Pneumococcal","enrollment":1712},{"nctId":"NCT00205803","phase":"PHASE1, PHASE2","title":"Study Evaluating Pneumococcal Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2004-09","conditions":"Healthy Subjects, Pneumococcal Infections","enrollment":249},{"nctId":"NCT00676091","phase":"PHASE3","title":"Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2008-04","conditions":"Vaccines, Pneumococcal Conjugate Vaccine","enrollment":354},{"nctId":"NCT00689351","phase":"PHASE2","title":"Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2008-06","conditions":"Pneumococcal Vaccine","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"7vPnC","genericName":"7vPnC","companyName":"Wyeth is now a wholly owned subsidiary of Pfizer","companyId":"wyeth-is-now-a-wholly-owned-subsidiary-of-pfizer","modality":"Biologic","firstApprovalDate":"","aiSummary":"7vPnC is a vaccine that protects against meningococcal disease caused by serogroups B and Y. Used for Prevention of meningococcal disease caused by serogroups B and Y in individuals 10 through 25 years of age.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}